🇺🇸 FDA
Pipeline program

NextDose (nextdose.org)

2020025

Approved other active

Quick answer

NextDose (nextdose.org) for Thrombosis Embolism is a Approved program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Thrombosis Embolism
Phase
Approved
Modality
other
Status
active

Clinical trials